In the press

Richard Williams comments on latest SEGRO offer in Investment Week

Biotech trusts top performance charts in February

Richard Williams comments on latest SEGRO offer from Prologis in Michael Nelson’s article:

“A larger exchange ratio and cash element will be well received, and although SEGRO has argued it has a clear valuation route to £13 per share, investors may well be tempted by ‘jam today’ rather than the promise of ‘jam tomorrow’.”

Read the article here